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Abstract
Of 415 patients, 200 undergoing aortic valve replacement (AVR) and 215 undergoing AVR in combination with myocardial revascularization 
[coronary artery bypass grafting (CABG)], had complete preoperative health-related quality of life (HRQOL) data. From this group, 224 
patients had a follow-up of one year. To assess HRQOL, the EuroQol instrument was used. The EQ-5D index score was calculated, based on 
separate scores from five health domains, to express the global health status of the patient. The EQ visual analogue scale (VAS) was used 
to describe patients’ subjective HRQOL. At baseline, the EQ-5D showed no significant differences between the two groups. The EQ-VAS 
score, however, was statistically significantly lower in the AVR + CABG patients (P = 0.031). At one year postoperatively, both groups showed 
a statistically significant increase in the EQ-VAS (P = 0.001 and P = 0.001, respectively) and the EQ-5D (P = 0.001 and P = 0.001, respectively). 
This increase, however, could only be ascertained for the domain ‘pain/discomfort’ (P = 0.001) in the AVR group, and for ‘mobility’  
(P = 0.018), ‘usual activities’ (P = 0.001), ‘pain/discomfort’ (P = 0.001) and ‘anxiety/depression’ (P = 0.001) in the AVR + CABG group. At 
baseline, coronary artery disease had a negative influence on the patients’ HRQOL, especially on the EQ-VAS. Postoperatively, all patients 
experienced significantly better HRQOL. However, the patients undergoing combined surgery experienced more benefit from their operation.
 2011 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
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1. Introduction
Improvements in survival and health-related quality of 
life (HRQOL) are the main goals of cardiac surgery [1, 2]. 
In patients undergoing aortic valve replacement (AVR), the 
combination with coronary artery disease (CAD) is known 
to negatively influence short- and long-term survival [3, 4]. 
Whether or not CAD influences HRQOL, however, preoper-
atively as well as postoperatively, is still questionable. This 
is important because, in several studies concerning HRQOL 
after valve surgery, patients with isolated or combined 
procedures were considered as one group [5, 6].
The aim of this study is to evaluate the influence of CAD 
on HRQOL in patients undergoing AVR. Additionally, if CAD 
appears to have no effect, both groups can continue to be 
combined in HRQOL evaluation after AVR surgery.
2. Patients and methods
2.1. Patients
With the aid of our database, the Coronary Surgery 
Database Radboud Hospital (CORRAD), we first identified 
549 consecutive patients aged 55 years or older who under-
went either an AVR or a combined aortic valve–coronary 
artery bypass operation (AVR + CABG) between October 
2006 and August 2010. Of this initial group, 415 (76%) 
patients completed the preoperative HRQOL (the total 
group). Thirty-nine patients were in New York Heart Asso-
ciation (NYHA) class IV, 286 patients were in NYHA class III, 
and the other 90 patients were in NYHA class I or II.
Second, a subset of 239 patients was identified for the 
one-year follow-up (patients operated on before May 2009). 
(It must be noted that this subgroup was only determined 
by the date of operation and the resulting possibility of a 
one-year follow-up.) Hospital mortality was seven (2.9%) 
patients, and during the first year another eight (3.3%) 
patients died. Of the remaining 224 patients, 50 were lost 
to follow-up or had incomplete postoperative data. There-
fore, pre- and postoperative data were available for 174 
(78%) patients (the follow-up group).
The total group consisted of 215 (52%) AVR + CABG patients, 
and the follow-up group of 102 (59%) AVR + CABG patients. 
The EuroSCORE was used for risk stratification [7]. Table 1 
presents the studied variables and their definitions.
2.2. Quality of life
For the evaluation of QOL, the EuroQol (EQ-5D) instru-
ment was used [8]. This is a standardized generic instru-
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ment to measure QOL, and its validity has been subs-
tantially corroborated. The EQ-5D consists of five domains 
of health (mobility, self-care, usual activities, pain/discom-
fort, and anxiety/depression), each of which is divided into 
three levels: no problems (1), some or moderate problems 
(2), and extreme problems (3). Based on the response to 
this classification, a single index value is estimated by 
applying a general population-based algorithm [9]. For 
example, state 21,312 leads to an EQ-5D index score of 
0.54. Possible scores span a scale from –0.54 (state 33,333) 
to 1.0 (state 11,111), the latter representing perfect 
health. An EQ-5D index score of zero corresponds to a 
HRQOL state that is all but death.
In addition, patients scaled their health on a visual ana-
logue scale (EQ-VAS) ranging from 0 to 100, with 0 as the 
worst possible health state and 100 as the best possible 
health state. Whereas the EQ-5D index can be regarded as 
a societal-based composite global HRQOL measure, the EQ-
VAS is a direct global HRQOL assessment from the patient’s 
perspective. In keeping with our previous work [10], we 
also evaluated the five domains of health separately by 
coding them from one (the best) to three (the worst) and 
by subsequently transposing these values to a metric scale.
2.3. Surgical technique
All patients were operated on using a standard cardiopul-
monary bypass technique, aortic and right atrial (two-
stage) cannulation, hypothermia (32–34 °C) and myocardial 
protection using crystalloid cardioplegia. For the patients 
undergoing only AVR, the mean time on extracorporeal 
circulation was 97 ± [standard deviation (S.D.)] 25 min 
(range 60–189) and the mean duration of aortic cross-
clamping was 67 ± 16 min (range 31–135 min). Of these 
patients, 176 (88%) received a biological and 24 (12%) a 
mechanical valve. For patients undergoing AVR + CABG, the 
mean time on extracorporeal circulation was 152 ± 40 min 
(range 75–272 min) and the mean duration of aortic cross-
clamping was 105 ± 27 min (range 55–205 min). In this 
group, the mean number of grafts was 1.5 ± 0.5 (range 1– 
2) with 2.5 ± 1.4 (range 1–7) distal anastomoses. Of all 
patients undergoing AVR + CABG, 65% received at least one 
arterial graft. In the AVR + CABG group, 191 (89%) patients 
received a biological and 24 (11%) patients a mechanical 
valve.
2.4. Follow-up
The HRQOL data resulted from our yearly-organized 
follow-up, a written survey sent directly to the patients. 
Both the preoperative and follow-up registration of data 
were approved by the Local Ethical and Research Council. 
Participation was on a voluntary basis [11].
2.5. Statistical analysis
Characteristics of patients are presented as percentage 
for dichotomous variables, and as mean ± S.D., and range 
for numerical variables. Differences in percentages were 
tested with the χ2-test and numerical variables were tested 
with the t-test or Mann–Whitney U-test when appropriate. 
Student’s t-tests were performed to examine the mean 
differences between pre- and postoperative HRQOL. Statis-
tical significance was assumed at P ≤ 0.05.
3. Results
The characteristics of the 415 patients in the total group 
are listed in Table 2. Analysis shows a significant difference 
in male:female ratio (P = 0.012), as well as a significantly 
higher prevalence of diabetes (P = 0.040), preoperative 
myo cardial infarction (MI) (P = 0.001) and renal failure 
(P = 0.010), additive EuroSCORE (P = 0.011) and logistic 
EuroSCORE (P = 0.007) in the AVR + CABG group. The cal-
culated EQ-5D index is not significantly different between 
the two groups, but the EQ-VAS score (P = 0.031) is, being 
significantly lower for the AVR + CABG group. The calculat-
ed means of the EQ-5D and the patient distribution within 
the five domains show no differences between the two 
groups (Table 3).
The follow-up group of 174 patients – 72 AVR and 102 
AVR + CABG – did not show any statistically significant 
difference in relation to the baseline characteristics, EQ-
5D index and EQ-VAS if compared with the total group 
(data not shown). At one year postoperatively, however, 
the EQ-5D index and the EQ-VAS score showed a significant 
increase for both the AVR group (P = 0.001 and P = 0.001, 
respectively) and the AVR + CABG group (P = 0.001 and 
P = 0.001, respectively) (Table 4). Considering the five 
domains of the EuroHRQOL, the AVR group only showed 
significant improvements with regard to the item ‘pain/
discomfort’ (P = 0.001). In the AVR + CABG group, aspects 
of ‘mobility’ (P = 0.018), ‘usual activity’ (P = 0.001) and 
‘anxiety’ (0.001), in addition to that of ‘pain/discomfort’ 
(P = 0.001), achieve statistically significant better scores.
4. Discussion
This study evaluates the influence of combined CAD in 
patients undergoing AVR surgery on HRQOL before and at 
Table 1. Variables and definitions
Variables Definitions
Age (years) Years
BMI Body mass index
Diabetes Diet-controlled, oral therapy or insulin-dependent diabetes
Vascular disease Peripheral, abdominal vascular pathology or operation
Neurological disease Cerebrovascular accidents and/or transient ischemic attack
Renal disease Renal failure (creatinine ≥200 μmol/l), preoperative dialysis
Pulmonary disease Chronic obstructive pulmonary disease and/or history of previous lung disease
Preoperative myocardial infarction (Pre-MI) History of myocardial infarction before the operation
Hospital mortality All mortality during the postoperative hospital stay after cardiac surgery
Institutional 
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one year postoperatively. In the present study, only patients 
aged 55 or older were included. This age limit is of course 
arbitrary but was applied because, in the AVR group, most 
patients under 55 years of age are operated on for congen-
ital aortic valve disease.
As other studies have shown [3, 12] that there is a higher 
percentage of women undergoing isolated AVR. A possible 
explanation is the lower prevalence of CAD among women 
[13], which is probably no different in patients with aortic 
valve disease. Another variable that reached a significant 
difference is the incidence of previous cardiac surgery. This 
corresponds with the studies of Kurlansky et al. [5] and 
Akins et al. [14]. It might be that these patients have often 
had prior CABG, yet the fact that they underwent an 
isolated AVR suggests that at that time there was no need 
for myocardial revascularization.
The significantly higher prevalence of diabetes, preoper-
ative MI and renal failure highlights the combination of 
CAD and associated diseases. The fact that the additive 
and logistic EuroSCOREs are significantly higher in the 
AVR + CABG group can be explained by the significantly 
higher prevalence of renal failure, some recent MI, regis-
Table 2. Baseline characteristics, EuroSCORE risk and health-related quality of life information for the total group
Variables Patients 
n = 415 (%)
AVR  
n = 200 (%)
AVR + CABG 
n = 215 (%)
AVR vs. AVR + CABG 
P-value
Age (years) 71.7 ± 7.3 (55–88) 71.1 ± 7.6 (55–88) 72.3 ± 7.1 (55–87) 0.081
Sex (male) 260 (62.7) 113 (56.5) 147 (68.4) 0.012
Body mass index 27.7 ± 4.6 (15.4–46.7) 27.9 ± 4.7 (15.4–46.7) 27.5 ± 4.5 (18.1–41.7) 0.358
Diabetes 95 (22.9) 37 (18.5) 58 (27.0) 0.040
Preoperative diuretics 112 (26.0) 47 (23.5) 65 (30.2) 0.123
Vascular disease 59 (14.2) 22 (11.0) 37 (17.2) 0.070
Neurological disease 26 (6.3) 8 (4.0) 18 (8.4) 0.066
Pulmonary disease 73 (17.6) 35 (17.5) 38 (17.7) 0.963
Renal failure 7 (1.7) 0 (0.0) 7 (3.3) 0.010
Pre-MI 50 (12.0) 11 (5.5) 39 (18.1) 0.001
Reoperation 16 (3.9) 12 (6.0) 4 (1.9) 0.029
Additive EuroSCORE 6.2 ± 2.2 (2–16) 5.9 ± 2.2 (2–16) 6.4 ± 2.2 (2–13) 0.011
Logistic EuroSCORE 6.9 ± 6.0 (1.51–69.1) 6.4 ± 6.5 (1.51–69.1) 7.3 ± 5.6 (1.51–38.4) 0.007
EQ-5D 0.72 ± 0.26 (–0.13–1.00) 0.72 ± 0.27 (0.0–1.00) 0.71 ± 0.26 (–0.13–1.00) 0.479
EQ-VAS 62.9 ± 19.3 (8–100) 64.8 ± 20.0 (8–100) 61.1 ± 18.5 (10–100) 0.031
AVR, Aortic valve replacement; AVR + CABG, combined aortic valve replacement and coronary artery bypass grafting; MI, myocardial infarction; VAS, visual 
analogue scale.
Table 3. The calculated means of the EQ-5D and the patient distribution within the five domains
Variables Patients  
n = 415 (%)
AVR  
n = 200 (%)
AVR + CABG  
n = 215 (%)
AVR vs. AVR + CABG 
P-value
Means ± S.D. of the different domains
 Mobility   1.50 ± 0.59  1.45 ± 0.59  1.54 ± 0.59 0.110
 Self-care   1.10 ± 0.36  1.10 ± 0.38  1.10 ± 0.36 0.942
 Usual activities   1.37 ± 0.57  1.32 ± 0.53  1.42 ± 0.60 0.068
 Pain/discomfort   1.69 ± 0.63  1.67 ± 0.64  1.72 ± 0.63 0.463
 Anxiety/depression   1.46 ± 0.57  1.48 ± 0.58  1.44 ± 0.57 0.504
Distribution of the patients in the different domains
 Mobility 0.105
 1 228 (54.9) 120 (60.0) 108 (50.2)
 2 165 (39.8)  69 (34.5)  96 (44.7)
 3  22 (5.3)  11 (5.5)  11 (5.1)
 Self-care 0.830
 1 381 (91.8) 184 (92.0) 197 (91.6)
 2  25 (6.0)  11 (5.5)  14 (6.5)
 3  9 (2.2)  5 (2.5)  4 (1.9)
 Usual activities 0.188
 1 280 (67.5) 143 (71.5) 137 (63.7)
 2 115 (27.7)  50 (25.0)  65 (30.2)
 3  20 (4.8)  7 (3.5)  13 (6.0)
 Pain/discomfort 0.660
 1 165 (39.8)  84 (42.0)  81 (37.7)
 2 210 (50.6)  97 (48.5) 113 (52.6)
 3  40 (9.6)  19 (9.5)  21 (9.8)
 Anxiety/depression 0.770
 1 242 (58.3) 113 (56.5) 129 (60.0)
 2 155 (37.3)  78 (39.0)  77 (35.8)
 3  18 (4.3)  9 (4.5)  9 (4.2)
AVR, Aortic valve replacement; AVR + CABG, combined aortic valve replacement and coronary artery bypass grafting; S.D., standard deviation.
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tered under MI, and the higher, although not significantly 
so, incidence of vascular and neurological disease, all risk 
variables of the EuroSCORE. The higher percentage of 
women, however, as well as the higher percentage of 
previous cardiac surgery in the AVR group, reduces the 
difference in calculated EuroSCORE.
Preoperatively, patients with significant CAD have a sig-
nificantly lower EQ-VAS score, but the EQ-5D score is in 
the same region. The calculated means and the distribution 
of the five domains of the EuroHRQOL registration show no 
significant differences either. Possible angina as a symptom 
of coronary atherosclerosis has more influence on the 
patient’s EQ-VAS.
At one year postoperatively, both groups show significant 
improvements for EQ-5D and EQ-VAS. This finding is in 
keeping with several other studies concerning AVR [6, 15]. 
For both groups, the increase in the EQ-5D is statistically 
significant. The mean score improvement in the AVR group 
is about 14% (from 0.71 to 0.81), and in the AVR + CABG 
group about 18% (from 0.69 to 0.82). This suggests that the 
increase in the EQ-5D is higher in the AVR + CABG group. 
Regarding the calculated means of the EQ-5D domains, it 
is clear that the AVR + CABG group has more benefits: four 
items improve significantly after the operation, compared 
with only one item in the AVR group. In both groups, there 
is a significant improvement for the domain ‘pain/discom-
fort’. Only in the AVR + CABG group, however, is there a 
significant improvement, with a decrease in the mean 
for the domain anxiety/depression; patients with CAD 
are probably more concerned they will suffer a MI, and 
these patients feel more confident after CABG. The signifi-
cant decrease for ‘usual activities’ and ‘mobility’ in the 
AVR + CABG probably has to do with the higher, although 
not significantly so, preoperative value for these domains. 
Which can be explained because of the CAD in these pa-
tients. Both groups show a statistically significant increase 
in the EQ-VAS. For the AVR group, it adds up to about 20% 
(from 62.5 to 76.0), and for the AVR + CABG group it is 21% 
(from 62.0 to 74.9).
Before drawing our conclusion, we must realize that the 
number of patients studied is small. Our total group, 
however, consists of 415 patients with a registered preop-
erative HRQOL. This is, to our knowledge, one of the largest 
groups with a documented preoperative HRQOL registration 
that has been published. Other work refers only to post-
operatively registered HRQOL [5]. The study of Sedrakyan 
et al. is the only one of our references that compares 
preoperatively and postoperatively registered HRQOL, but 
their study group consists of only 220 patients [6]. Our 
follow-up group is smaller (174 patients) and follow-up is 
restricted to only one year, but again this is one of the rare 
studies with pre- and postoperative HRQOL information. 
Other remarks about the use of the EuroQol and the fact 
that we evaluate the five domains of health separately, 
transposing these values to a metric scale, and about the 
influence of comorbidity during follow-up, have already 
been discussed in our previous paper [10]. The fact that, 
in the total group (24%), as in the follow-up group (22%), 
patients could not be included because of a lack of QOL 
data has several reasons: participation was on a voluntary 
basis [15], but also, and this was certainly true in the 
follow-up group, we analysed only complete cases, so that 
subjects with missing values were excluded from analysis.
Despite these limitations, we conclude that, at baseline, 
CAD has a negative influence on the patient’s HRQOL, 
especially the EQ-VAS (the patient’s subjective perspec-
tive). Postoperatively, both groups experienced a better 
HRQOL. According to the HRQOL domains, however, 
patients who underwent AVR + CABG surgery experienced a 
more comprehensive improvement. Because CAD has a 
negative influence on the baseline HRQOL of the patients, 
and because patients who undergo combined surgery expe-
rience more benefit from the operation, it does not seem 
opportune to combine these two groups for the evaluation 
of HRQOL after AVR. In order to confirm our conclusions, 
however, further larger studies are necessary.
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